Trademark Overview
On Monday, July 22, 2024, a trademark application was filed for CELLTOLERANCE with the United States Patent and Trademark Office. The USPTO has given the CELLTOLERANCE trademark a serial number of 79408132. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 31, 2024. This trademark is owned by MAUNA KEA TECHNOLOGIES. The CELLTOLERANCE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Health care services for human beings; medical care services; medical analysis services; medical services for the remote analysis of optical samples and diagnosis on cells; medical services relating to the collection, treatment and processing of human cells; medical assessment of health status; medical diagnosis services; medical diagnostic and testing services in relation to digestive and gastrointestinal diseases and disorders; medical tests for diagnostic or treatment purposes; developing care protocols in relation to digestive and gastrointestinal diseases and disorders; providing news and information in the field of medicine; provision of information relating to medical services; provision of medical information in the field of health; providing medical information in the field of gastroenterology; individual medical advisory services provided to patients; medical analysis services relating to the treatment of patients; medical testing for the diagnosis and treatment of persons.
Scientific and technological services as well as research and design services relating thereto; industrial analysis and research services; Development of new technology on behalf of third parties in the field of biotechnology; providing information in medical and scientific research in the field of clinical trials; providing medical and scientific research information in the pharmaceutical field; research and development in the field of pharmaceuticals and biotechnology; analyzing, assessing and reporting diagnostic test results and diagnostic or prognostic tests of residual disease to assist healthcare professionals in the clinical diagnosis of a patient, to assess the effectiveness of treatments prescribed to patients and change future treatments accordingly; medical and scientific research in the field of treatment and diagnosis of digestive and gastrointestinal diseases and disorders.
